Roche Molecular Systems, Inc.

Roche Diagnostics Gmbh

F. Hoffmann-La Roche Ag

Kalyani Mangipudi

Stephen Gordon Will

Jody Harris

Eugene G Spier

Jenny A Johnson

Jingtao Sun

Shi-Da Y Lu

Barbara Eckert

Kyle C Cady

Chitra Manohar

Christopher David Santini

Marintha Heil

Marcel Fontecha

Patrick Lin

Shi Da Lu

Hai Nguyen

Huan Truong

Kristina Chu

Dylan Goldman

Misha Mehta

Arrash Moghaddasi

Natacha Sorenson

Michelle Elizabeth Yee

Thanh Tam

Ramani Sadanandam Ravirala

Colin Lam

Jeffrey Alexander

Shi Da Y Lu

Methods for the rapid detection of the presence or absence of(MG) in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers, probes targeting the target MG gene, along with kits are provided that are designed for the detection of MG.

Compositions and methods for detection of

Methods for the rapid detection of the presence or absence of SARS-CoV-2, influenza A and influenza B in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers and probes targeting SARS-CoV-2, influenza A, and influenza B and kits are provided that are designed for the detection of SARS-CoV-2, influenza A and influenza B.

Compositions and methods for detecting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A and Influenza B

Methods for the rapid detection of the presence or absence of(TV) in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers, probes targeting the target TV gene, along with kits are provided that are designed for the detection of TV.

The present invention relates to compositions comprising and methods of producing genetically engineered bacteriophages, bacteriophage-like particles and non-replicating transduction particles (NRTPs) that contain non-native tail fibers that display altered host specificity and/or reactivity. The present invention also relates to methods of using these bacteriophages and NRTPs for the development of novel diagnostics, therapeutics and/or research reagents for bacteria-related diseases.

Non-replicative transduction particles with one or more non-native tail fibers and transduction particle-based reporter systems

Compositions and methods for detection of trichomonas vaginalis

Growing community of inventors

Pleasanton, CA, United States of America

Kalyani Mangipudi